MXC launches MGC Nutraceuticals Product Line

Company News

by Anna Napoli

Medical cannabis company MGC Pharma (ASX:MXC) has announced the launch of MGC Nutraceuticals.

The new product line offers a range of premium vegan products for the high-end dietary supplement market.

The company says the global nutraceutical market was valued at about $383 billion US dollars in 2016 and is expected to grow to over $500 billion by 2022

The European based business says the new range leverages the company’s existing medicinal cannabis IP.

Shares in MGC Pharma (ASX:MXC) are trading 3.19 per cent higher to 10 cents.


Anna Napoli

Finance News Network
Anna joined FNN February 2018 and also works with Channel 7 as a freelance producer. Anna has also worked as a lawyer and lecturer. She has also presented news updates for interstate news with Southern Cross Austereo.